Submitted by Anonymous (not verified) on 20 July 2026 - 15:38
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 13, Status: Authorised
Source: